Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand

Triple-negative breast cancer (TNBC) is a heterogeneous disease in which the tumors do not express estrogen receptor (ER), progesterone receptor (PgR) or human epidermal growth factor receptor 2 (HER2). Classical receptor-targeted therapies such as tamoxifen or trastuzumab are therefore unsuitable a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Amoury, Manal, Bauerschlag, Dirk, Zeppernick, Felix, von Felbert, Verena, Berges, Nina, Di Fiore, Stefano, Mintert, Isabell, Bleilevens, Andreas, Maass, Nicolai, Bräutigam, Karen, Meinhold-Heerlein, Ivo, Stickeler, Elmar, Barth, Stefan, Fischer, Rainer, Hussain, Ahmad Fawzi
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342391/
https://ncbi.nlm.nih.gov/pubmed/27448975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10705
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars